Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis

GLIA

Volumn 51, Issue 4, 2005, Pages 241-253

  Sargsyan, Siranush A ^a   Monk, Peter N ^a   Shaw, Pamela J ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cytokines; Microglia; Motor neuron; Neuroinflammation

Indexed keywords

CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR; COLONY STIMULATING FACTOR 1; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOOXYGENASE 2; DOXORUBICIN; FRACTALKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION PROFILING; HUMAN; INFLAMMATION; MICROGLIA; MOTONEURON; NERVE INJURY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE ABILITY; SIGNAL TRANSDUCTION; TISSUE DEGENERATION; ANIMAL; ANIMAL MODEL; GLIOSIS; IMMUNOLOGY; METABOLISM; MOUSE; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE PROGRESSION; GLIOSIS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MICE; MICROGLIA; MODELS, ANIMAL; MOTOR NEURONS; NERVE DEGENERATION; SIGNAL TRANSDUCTION;

EID: 25444522220     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20210     Document Type: Article

References (138)

1. Alexianu ME, Kozovska M, Appel SH. 2001. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57:1282-1289.
2. Almer G, Vukosavic S, Romero N, Przedborski S. 1999. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 72:2415-2425.
3. Almer G, Guegan C, Teismann P, Naini A, Rosoklija G, Hays AP, Chen C, Przedborski S. 2001. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 49:176-185.
4. 2 in CSF from ALS patients. Neurology 58:1277-1279.
5. Andersen PM. 2003. Genetic aspects of amyotrophic lateral sclerosis/motor neuron disease. In: Shaw PJ, Strong MJ, editors. Motor neuron disorders. Philadelphia, PA: Butterworth Heinemann, p 207-235.
6. Anneser JMH, Chahli C, Ince PG, Borasio GD, Shaw PJ. 2004. Glial proliferation and metabotropic glutamate receptor expression in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 63:831-40.
7. Baldwin AS Jr. 2001. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 107:3-6.
8. Banati RB, Gehrmann J, Kellner M, Holsboer F. 1995. Antibodies against microglia/macrophages in the cerebrospinal fluid of a patient with acute amyotrophic lateral sclerosis and presenile dementia. Clin Neuropathol 14:197-200.
9. 3H]PK11195 binding to activated microglia. J Neurocytol 26:77-82.
10. Barger SW, Harmon AD. 1997. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388: 878-881.
11. Barron KD, Marciano FF, Amundson R, Mankes R. 1990. Perineuronal glial responses after axotomy of central and peripheral axons. A comparison. Brain Res 523:219-229.
12. Bartholdi D, Schwab ME. 1997. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci 9:1422-1438.
13. Beuche W, Yushchenko M, Mader M, Maliszewska M, Felgenhauer K, Weber F. 2000. Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. NeuroReport 11:3419-3422.
14. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, Volterra A. 2001. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4:702-710.
15. Boehme SA, Lio FM, Maciejewski-Lenoir D, Bacon KB, Conlon PJ. 2000. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol 165:397-403.
16. Bohatschek M, Kloss CU, Hristova M, Pfeffer K, Raivich G. 2004. Microglial major histocompatibility complex glycoprotein-1 in the axotomized facial motor nucleus: regulation and role of tumor necrosis factor receptors 1 and 2. J Comp Neurol 470:382-399.
17. Boje KM, Arora PK. 1992. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 587:250-256.
18. Bos CL, Richel DJ, Ritsema T, Peppelenbosch MP, Versteeg HH. 2004. Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol 36:1187-1205.
19. Bronstein DM, Perez-Otano I, Sun V, Mullis Sawin SB, Chan J, Wu GC, Hudson PM, Kong LY, Hong JS, McMillian MK. 1995. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res 704:112-116.
20. Bruccoleri A, Brown H, Harry GJ. 1998. Cellular localization and temporal elevation of tumor necrosis factor-alpha, interleukin-1 alpha, and transforming growth factor-beta 1 mRNA in hippocampal injury response induced by trimethyltin. J Neurochem 71:1577-1587.
21. Bruijn LI, Miller TM, Cleveland DW. 2004. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27:723-749.
22. Caggiano AO, Kraig RP. 1999. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J Neurochem 72:565-575.
23. Chandel NS, Schumacker PT, Arch RH. 2001. Reactive oxygen species are downstream products of TRAF-mediated signal transduction. J Biol Chem 276:42728-42736.
24. Chang RC, Hudson P, Wilson B, Haddon L, Hong JS. 2000. Influence of neurons on lipopolysaccharide-stimulated production of nitric oxide and tumor necrosis factor-alpha by cultured glia. Brain Res 853:236-244.
25. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. 1992. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 149:2736-2741.
26. Chapman GA, Moores K, Harrison D, Campbell CA, Stewart BR, Strijbos PJ. 2000. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J Neurosci 20:RC87.
27. Chen DH. 1978. Qualitative and quantitative study of synaptic displacement in chromatolyzed spinal motoneurons of the cat. J Comp Neurol 177:635-664.
28. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, Rule M, McMahon AP, Doucette W, Siwek D, Ferrante RJ, Brown RH Jr, Julien JP, Goldstein LS, Cleveland DW. 2003. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302:113-117.
29. Comoletti D, Muzio V, Capobianco A, Ravizza T, Mennim T. 2001. Nitric oxide produced by non-motoneuron cells enhances rat embryonic motoneuron sensitivity to excitotoxins: comparison in mixed neuron/ glia or purified cultures. J Neurol Sci 192:61-69.
30. Consilvio C, Vincent AM, Feldman EL. 2004. Neuroinflammation, COX-2, and ALS-a dual role? Exp Neurol 187:1-10.
31. Cook DN, Chen SC, Sullivan LM, Manfra DJ, Wiekowski MT, Prosser DM, Vassileva G, Lira SA. 2001. Generation and analysis of mice lacking the chemokine fractalkine. Mol Cell Biol 21:3159-3165.
32. Cuadros MA, Navascues J. 1998. The origin and differentiation of microglial cells during development. Prog Neurobiol 56:173-189.
33. Eikelenboom P, Bate C, Van Gool WA, Hoozemans JJ, Rozemuller JM, Veerhuis R, Williams A. 2002. Neuroinflammation in Alzheimer's disease and prion disease. Glia 40:232-239.
34. Elliott JL. 2001. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Brain Res 95: 172-178.
35. Eskes C, Juillerat-Jeanneret L, Leuba G, Honegger P, Monnet-Tschudi F. 2003. Involvement of microglia-neuron interactions in the tumor necrosis factor-alpha release, microglial activation, and neurodegeneration induced by trimethyltin. J Neurosci Res 71:583-590.
36. Ferri A, Nencini M, Casciati A, Cozzolino M, Angelini DF, Longone P, Spalloni A, Rotilio G, Carri MT. 2004. Cell death in amyotrophic lateral sclerosis: interplay between neuronal and glial cells. FASEB J 18:1261-1263.
37. Flynn G, Maru S, Loughlin J, Romero IA, Male D. 2003. Regulation of chemokine receptor expression in human microglia and astrocytes. J Neuroimmunol 136:84-93.
38. Galiano M, Liu ZQ, Kalla R, Bohatschek M, Koppius A, Gschwendtner A, Xu S, Werner A, Kloss CU, Jones LL, Bluethmann H, Raivich G. 2001. Interleukin-6 (IL6) and cellular response to facial nerve injury: effects on lymphocyte recruitment, early microglial activation and axonal outgrowth in IL6-deficient mice. Eur J Neurosci 14:327-341.
39. Garden GA. 2002. Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 40:240-251.
40. Gary DS, Bruce-Keller AJ, Kindy MS, Mattson MP. 1998. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 18:1283-1287.
41. Gong YH, Parsadanian AS, Andreeva A, Snider WD, Elliott JL. 2000. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J Neurosci 20:660-665.
42. Goodwin JL, Uemura E, Cunnick JE. 1995. Microglial release of nitric oxide by the synergistic action of beta-amyloid and IFN-gamma. Brain Res 692:207-214.
43. Graeber MB, Streit WJ, Kreutzberg GW. 1989. Formation of microglia-derived brain macrophages is blocked by adriamycin. Acta Neuropathol (Berl) 78:348-358.
44. Gurney ME, Cutting FB, Zhai P, Andrus PK, Hall ED. 1996. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase. Pathol Biol (Paris) 44:51-56.
45. Hall ED, Oostveen JA, Gurney ME. 1998. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23:249-256.
46. Hanisch UK. 2002. Microglia as a source and target of cytokines. Glia 40:140-155.
47. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, Botti P, Bacon KB, Feng L. 1998. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 95:10896-10901.
48. Hatori K, Nagai A, Heisel R, Ryu JK, Kim SU. 2002. Fractalkine and fractalkine receptors in human neurons and glial cells. J Neurosci Res 69:418-426.
49. Hausler KG, Prinz M, Nolte C, Weber JR, Schumann RR, Kettenmann H, Hanisch UK. 2002. Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages. Eur J Neurosci 16:2113-2122.
50. He BP, Wen W, Strong MJ. 2002. Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro. J Neuroimmunol 128:31-38.
51. Heath PR, Shaw PJ. 2002. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve 46:438-458.
52. Hemmer K, Fransen L, Vanderstichele H, Vanmechelen E, Heuschling P. 2001. An in vitro model for the study of microglia-induced neurodegeneration: involvement of nitric oxide and tumor necrosis factor-alpha. Neurochem Int 38:557-565.
53. Henkel JS, Engelhardt JI, Siklos L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T, Beers DR, Appel SH. 2004. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55:221-235.
54. Hensley K, Floyd RA, Gordon B, Mou S, Pye QN, Stewart C, West M, Williamson K. 2002. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J Neurochem 82:365-374.
55. Hensley K, Fedynyshyn J, Ferrell S, Floyd RA, Gordon B, Grammas P, Hamdheydari L, Mhatre M, Mou S, Pye QN, Stewart C, West M, West S, Williamson KS. 2003. Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol Dis 14:74-80.
56. Hoffmann CF, Choufoer H, Marani E, Thomeer RT. 1993. Ultrastructural study on avulsion effects of the cat cervical moto-axonal pathways in the spinal cord. Clin Neurol Neurosurg 95(suppl):S39-47.
57. Huuskonen J, Suuronen T, Nuutinen T, Kyrylenko S, Salminen A. 2004. Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids. Br J Pharmacol 141:874-880.
58. Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, Morham S, Ross ME. 2001. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci USA 98:1294-1299.
59. 2 is increased in amyotrophic lateral sclerosis patients. Acta Neurol Scand 108:125-129.
60. Ilzecka J, Stelmasiak Z, Dobosz B. 2002. Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis. Cytokine 20:239-243.
61. Inoue K. 2002. Microglial activation by purines and pyrimidines. Glia 40:156-163.
62. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR. 2000. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20:4106-4114.
63. Kaltschmidt C, Kaltschmidt B, Lannes-Vieira J, Kreutzberg GW, Wekerle H, Baeuerle PA, Gehrmann J. 1994. Transcription factor NF-kappa B is activated in microglia during experimental autoimmune encephalomyelitis. J Neuroimmunol 55:99-106.
64. Kawamata T, Akiyama H, Yamada T, McGeer PL. 1992. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 140:691-707.
65. Kerr BJ, Patterson PH. 2004. Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse. Exp Neurol 188:391-407.
66. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS. 2000. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20:6309-6316.
67. Kitanaka J, Hashimoto H, Gotoh M, Kondo K, Sakata K, Hirasawa Y, Sawada M, Suzumura A, Marunouchi T, Matsuda T, Baba A. 1996. Expression pattern of messenger RNAs for prostanoid receptors in glial cell cultures. Brain Res 707:282-287.
68. Klivenyi P, Kiaei M, Gardian G, Calingasan NY, Beal MF. 2004. Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem 88:576-582.
69. Koliatsos VE, Price WL, Pardo CA, Price DL. 1994. Ventral root avulsion: an experimental model of death of adult motor neurons. J Comp Neurol 342:35-44.
70. Lee P, Lee J, Kim S, Lee MS, Yagita H, Kim SY, Kim H, Suk K. 2001. NO as an autocrine mediator in the apoptosis of activated microglial cells: correlation between activation and apoptosis of microglial cells. Brain Res 892:380-385.
71. Lino MM, Schneider C, Caroni P. 2002. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci 22:4825-4832.
72. Maihofner C, Probst-Cousin S, Bergmann M, Neuhuber W, Neundorfer B, Heuss D. 2003. Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis. Eur J Neurosci 18:1527-1534.
73. McGeer PL, McGeer EG. 2002. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26:459-470.
74. Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, Ferrari D, Rossi F. 1995. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374:647-650.
75. Meucci O, Fatatis A, Simen AA, Miller RJ. 2000. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA 97:8075-8080.
76. Mielke K, Herdegen T. 2002. Fatal shift of signal transduction is an integral part of neuronal differentiation: JNKs realize TNFalpha-mediated apoptosis in neuronlike, but not naive, PC12 cells. Mol Cell Neurosci 20:211-224.
77. Minghetti L, Levi G. 1998. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol 54:99-125.
78. 2 and by cyclooxygenase inhibitors. Glia 19:152-160.
79. Mizuno T, Kurotani T, Komatsu Y, Kawanokuchi J, Kato H, Mitsuma N, Suzumura A. 2004. Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology 46:404-411.
80. Mizuno T, Yoshihara Y, Kagamiyama H, Ohsawa K, Imai Y, Kohsaka S, Mori K. 1999. Neuronal adhesion molecule telencephalin induces rapid cell spreading of microglia. Brain Res 849:58-66.
81. Morgan SC, Taylor DL, Pocock JM. 2004. Microglia release activators of neuronal proliferation mediated by activation of mitogen-activated protein kinase, phosphatidylinositol-3-kinase/Akt and delta-Notch signalling cascades. J Neurochem 90:89-101.
82. Moss DW, Bates TE. 2001. Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function. Eur J Neurosci 13: 529-538.
83. Nakajima K, Tohyama Y, Kohsaka S, Kurihara T. 2004. Protein kinase C alpha requirement in the activation of p38 mitogen-activated protein kinase, which is linked to the induction of tumor necrosis factor alpha in lipopolysaccharide-stimulated microglia. Neurochem Int 44:205-214.
84. Nakamura Y. 2002. Regulating factors for microglial activation. Biol Pharm Bull 25:945-953.
85. Nguyen MD, Julien JP, Rivest S. 2001. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. Ann Neurol 50:630-639.
86. Nishiyori A, Minami M, Ohtani Y, Takami S, Yamamoto J, Kawaguchi N, Kume T, Akaike A, Satoh M. 1998. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett 429:167-172.
87. Nomoto Y, Yamamoto M, Fukushima T, Kimura H, Ohshima K, Tomonaga M. 2001. Expression of nuclear factor kappaB and tumor necrosis factor alpha in the mouse brain after experimental thermal ablation injury. Neurosurgery 48:158-166.
88. Ohno M, Komiyama A, Martin PM, Suzuki K. 1993. Proliferation of microglia/macrophages in the demyelinating CNS and PNS of twitcher mouse. Brain Res 602:268-274.
89. Pasinelli P, Belford ME, Lennon N, Bacskai BJ, Hyman BT, Trotti D, Brown RH Jr. 2004. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43:19-30.
90. Pehar M, Cassina P, Vargas MR, Castellanos R, Viera L, Beckman JS, Estevez AG, Barbeito L. 2004. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem 89:464-473.
91. Piehl F, Lundberg C, Khademi M, Bucht A, Dahlman I, Lorentzen JC, Olsson T. 1999. Non-MHC gene regulation of nerve root injury induced spinal cord inflammation and neuron death. J Neuroimmunol 101:87-97.
92. Poloni M, Facchetti D, Mai R, Micheli A, Agnoletti L, Francolini G, Mora G, Camana C, Mazzini L, Bachetti T. 2000. Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett 287:211-214.
93. Pompl PN, Ho L, Bianchi M, McManus T, Qin W, Pasinetti GM. 2003. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J 17: 725-727.
94. Pralong E, Vesin MF, Droz B. 1990. Prostaglandin E2 receptors in the chicken spinal cord. 2. Radioautographic localization. Eur J Neurosci 2:904-908.
95. Pramatarova A, Laganiere J, Roussel J, Brisebois K, Rouleau GA. 2001. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci 21: 3369-3374.
96. Prewitt CM, Niesman IR, Kane CJ, Houle JD. 1997. Activated macrophage/microglial cells can promote the regeneration of sensory axons into the injured spinal cord. Exp Neurol 148:433-443.
97. Raivich G, Bohatschek M, Da Costa C, Iwata O, Galiano M, Hristova M, Nateri AS, Makwana M, Riera-Sans L, Wolfer DP, Lipp HP, Aguzzi A, Wagner EF, Behrens A. 2004. The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron 43:57-67.
98. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW. 1999. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Rev 30:77-105.
99. Raivich G, Gehrmann J, Kreutzberg GW. 1991. Increase of macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor receptors in the regenerating rat facial nucleus. J Neurosci Res 30:682-686.
100. Raivich G, Jones LL, Kloss CU, Werner A, Neumann H, Kreutzberg GW. 1998. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J Neurosci 18: 5804-5816.
101. Raivich G, Liu ZQ, Kloss CU, Labow M, Bluethmann H, Bohatschek M. 2002. Cytotoxic potential of proinflammatory cytokines: combined deletion of TNF receptors TNFR1 and TNFR2 prevents motoneuron cell death after facial axotomy in adult mouse. Exp Neurol 178:186-193.
102. Rapalino O, Lazarov-Spiegler O, Agranov E, Velan GJ, Yoles E, Fraidakis M, Solomon A, Gepstein R, Katz A, Belkin M, Hadani M, Schwartz M. 1998. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 4:814-821.
103. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. 1995. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 92:689-693.
104. Rogers J, Strohmeyer R, Kovelowski CJ, Li R. 2002. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 40:260-269.
105. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX. 1993. Mutations in Cu/ Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62.
106. Rowland LR. 2003.Clinical aspects of sporadic amyotrophic lateral sclerosis/motor neuron disease. In: Shaw PJ, Strong MJ, editors. Motor neuron disorders. Philadelphia, PA: Butterworth Heinemann, p 111-143.
107. Scali C, Giovannini MG, Prosperi C, Bellucci A, Pepeu G, Casamenti F. 2003. The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo. Neuroscience 117:909-919.
108. Schwab ME, Brosamle C. 1997. Regeneration of lesioned corticospinal tract fibers in the adult rat spinal cord under experimental conditions. Spinal Cord 35:469-473.
109. Sedel F, Bechade C, Vyas S, Triller A. 2004. Macrophage-derived tumor necrosis factor alpha, an early developmental signal for motoneuron death. J Neurosci 24:2236-2246.
110. Sherman MP, Griscavage JM, Ignarro LJ. 1992. Nitric oxide-mediated neuronal injury in multiple sclerosis. Med Hypotheses 39:143-146.
111. Sterman AB, Sposito N. 1984. Motoneuron axosomatic synapses are altered in axonopathy. J Neuropathol Exp Neurol 43:201-209.
112. Streit WJ. 2002. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133-139.
113. Streit WJ, Kreutzberg GW. 1988. Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J Comp Neurol 268:248-263.
114. Streit WJ, Walter SA, Pennell NA. 1999. Reactive microgliosis. Prog Neurobiol 57:563-581.
115. Sudo S, Tanaka J, Toku K, Desaki J, Matsuda S, Arai T, Sakanaka M, Maeda N. 1998. Neurons induce the activation of microglial cells in vitro. Exp Neurol 154:499-510.
116. Suzuki T, Hide I, Ido K, Kohsaka S, Inoue K, Nakata Y. 2004. Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J Neurosci 24:1-7.
117. Tikka TM, Vartiainen NE, Goldsteins G, Oja SS, Andersen PM, Marklund SL, Koistinaho J. 2002. Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease. Brain 125:722-731.
118. Tortarolo M, Veglianese P, Calvaresi N, Botturi A, Rossi C, Giorgini A, Migheli A, Bendotti C. 2003. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci 23:180-192.
119. Toulmond S, Rothwell NJ. 1995. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res 671:261-266.
120. Troost D, Claessen N, van den Oord JJ, Swaab DF, de Jong JM. 1993. Neuronophagia in the motor cortex in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 19:390-397.
121. Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, Leigh PN, Banati RB. 2004. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15: 601-609.
122. 2+-permeable AMPA receptors and selective vulnerability of motor neurons. J Neurol Sci 180:29-34.
123. Vandenberghe W, Van Den Bosch L, Robberecht W. 1998. Glial cells potentiate kainate-induced neuronal death in a motoneuron-enriched spinal coculture system. Brain Res 807:1-10.
124. 2 receptors on motoneurons. Adv Prostaglandin Thromboxane Leukot Res 213:735-738.
125. Viviani B, Corsini E, Galli CL, Marinovich M. 1998. Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha. Toxicol Appl Pharmacol 150:271-276.
126. Walton KM, DiRocco R, Bartlett BA, Koury E, Marcy VR, Jarvis B, Schaefer EM, Bhat RV. 1998. Activation of p38MAPK in microglia after ischemia. J Neurochem 70:1764-1767.
127. West M, Mhatre M, Ceballos A, Floyd RA, Grammas P, Gabbita SP, Hamdheydari L, Mai T, Mou S, Pye QN, Stewart C, West S, Williamson KS, Zemlan F, Hensley K. 2004. The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor α activation of microglia and extends survival of G93A-SOD1 transgenic mice. J Neurochem 91:133-143.
128. Weydt P, Yuen EC, Ransom BR, Moller T. 2004. Increased cytotoxic potential of microglia from ALS-transgenic mice. Glia 48: 179-182.
129. Wilms H, Sievers J, Dengler R, Bufler J, Deuschl G, Lucius R. 2003. Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration. J Neuroimmunol 144: 139-142.
130. Xie Y, Weydt P, Howland DS, Kliot M, Möller T. 2004. Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 rats. NeuroReport 15:2513-2516.
131. Yachnis AT, Giovanini MA, Eskin TA, Reier PJ, Anderson DK. 1998. Developmental patterns of BCL-2 and BCL-X polypeptide expression in the human spinal cord. Exp Neurol 150:82-97.
132. Yasojima K, Tourtellotte WW, McGeer EG, McGeer PL. 2001. Marked increase in cyclooxygenase-2 in ALS spinal cord: implications for therapy. Neurology 57:952-956.
133. Yoshida Y, Une F, Utatsu Y, Nomoto M, Furukawa Y, Maruyama Y, Machigashira N, Matsuzaki T, Osame M. 1999. Adenosine and neopterin levels in cerebrospinal fluid of patients with neurological disorders. Intern Med 38:133-139.
134. Yoshihara T, Ishigaki S, Yamamoto M, Liang Y, Niwa J, Takeuchi H, Doyu M, Sobue G. 2002. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 80:158-167.
135. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J. 1998. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95:15769-15774.
136. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. 1999. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96:13496-13500.
137. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu du C, Gullans S, Ferrante RJ, Przedborski S, Kristal BS, Friedlander RM. 2002. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417:74-78.
138. Zujovic V, Benavides J, Vige X, Carter C, Taupin V. 2000. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 29:305-315.